Effects of electroacupuncturing at Feishu (BL 13) on postoperative respiratory function for patients having laparoscopic radical resection of colon cancer

注册号:

Registration number:

ITMCTR2100004248

最近更新日期:

Date of Last Refreshed on:

2020-10-12

注册时间:

Date of Registration:

2020-10-12

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

电针肺俞穴对腹腔镜结肠癌患者术后呼吸功能的影响

Public title:

Effects of electroacupuncturing at Feishu (BL 13) on postoperative respiratory function for patients having laparoscopic radical resection of colon cancer

注册题目简写:

English Acronym:

研究课题的正式科学名称:

电针肺俞穴对腹腔镜结肠癌患者术后呼吸功能的影响

Scientific title:

Effects of electroacupuncturing at Feishu (BL 13) on postoperative respiratory function for patients having laparoscopic radical resection of colon cancer

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2000038996 ; ChiMCTR2100004248

申请注册联系人:

谢鹏程

研究负责人:

谢鹏程

Applicant:

Pengcheng Xie

Study leader:

Pengcheng Xie

申请注册联系人电话:

Applicant telephone:

+86 15800334356

研究负责人电话:

Study leader's telephone:

+86 15800334356

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

xpch-xz@163.com

研究负责人电子邮件:

Study leader's E-mail:

xpch-xz@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

上海市浦东新区惠南镇拱为路2800号

研究负责人通讯地址:

上海市浦东新区惠南镇拱为路2800号

Applicant address:

2800 Gongwei Road, Huinan Town, Pudong New Area, Shanghai, China

Study leader's address:

2800 Gongwei Road, Huinan Town, Pudong New Area, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

201399

研究负责人邮政编码:

Study leader's postcode:

201399

申请人所在单位:

上海市浦东医院;复旦大学附属浦东医院

Applicant's institution:

Shanghai Pudong Hospital; Fudan University Pudong Medical Center

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2020-WZ-021

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

上海市浦东医院伦理委员会

Name of the ethic committee:

Human Research Ethics Committee of the Shanghai Pudong Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2020/1/1 0:00:00

伦理委员会联系人:

金惠敏

Contact Name of the ethic committee:

Huimin Jin

伦理委员会联系地址:

上海市浦东新区惠南镇拱为路2800号

Contact Address of the ethic committee:

2800 Gongwei Road, Huinan Town, Pudong New Area, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海市浦东医院;复旦大学附属浦东医院

Primary sponsor:

Shanghai Pudong Hospital; Fudan University Pudong Medical Center

研究实施负责(组长)单位地址:

上海市浦东新区惠南镇拱为路2800号

Primary sponsor's address:

2800 Gongwei Road, Huinan Town, Pudong New Area, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市浦东医院;复旦大学附属浦东医院

具体地址:

浦东新区惠南镇拱为路2800号

Institution
hospital:

Shanghai Pudong Hospital; Fudan University Pudong Medical Center

Address:

2800 Gongwei Road, Huinan Town, Pudong New Area

经费或物资来源:

Source(s) of funding:

self-raised

研究疾病:

肺功能受损

研究疾病代码:

Target disease:

Impaired pulmonary function

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

验证电针肺俞穴是否能够有效促进腹腔镜结肠癌根治手术患者术后肺功能的恢复。

Objectives of Study:

To verify whether electroacupuncturing at Feishu (BL 13) can effectively promote the recovery of pulmonary function in patients undergoing laparoscopic radical resection of colon cancer.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

1 ASA I-III 级; 2 心功能1-2级; 3 年龄40-80岁; 4 血压控制正常; 5 能够配合治疗; 6 意识清醒; 7 能够保持俯卧位。

Inclusion criteria

1. ASA I-III patients; 2. Patients with cardiac function grade 1-2; 3. Patients aged 40-80 years old; 4. Patients with normal blood pressure control; 5. Patients who can cooperate with treatment; 6. Conscious patients; 7. Patients who can keep prone position.

排除标准:

1 电针部位感染; 2 胸部畸形; 3 胸肺部手术史; 4 慢性阻塞性肺疾病; 5 支气管扩张; 6 凝血功能异常; 7 病态肥胖; 8 心理障碍。

Exclusion criteria:

1. Patients with infection of electroacupuncture site; 2. Patients with chest deformity; 3. Patients with history of chest and lung surgery; 4. Patients with chronic obstructive pulmonary disease; 5. Patients with bronchiectasis; 6. Patients with abnormal coagulation function; 7. Morbidly obese patients; 8. Patients with mental disorders.

研究实施时间:

Study execute time:

From 2020-01-01

To      2022-12-31

征募观察对象时间:

Recruiting time:

From 2020-10-13

To      2021-01-31

干预措施:

Interventions:

组别:

组A

样本量:

30

Group:

Group A

Sample size:

干预措施:

不电针

干预措施代码:

Intervention:

do not electroacupuncturing

Intervention code:

组别:

组B

样本量:

30

Group:

Group B

Sample size:

干预措施:

电针肺俞穴

干预措施代码:

Intervention:

electroacupuncturing at Feishu (BL 13)

Intervention code:

样本总量 Total sample size : 60

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市浦东医院;复旦大学附属浦东医院

单位级别:

三级

Institution/hospital:

Shanghai Pudong Hospital; Fudan University Pudong Medical Center

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

病人满意度

指标类型:

次要指标

Outcome:

patients' satisfaction

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血压

指标类型:

次要指标

Outcome:

blood pressure

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血气

指标类型:

主要指标

Outcome:

blood gas

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肺功能

指标类型:

主要指标

Outcome:

pulmonary function

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心率

指标类型:

次要指标

Outcome:

heart rates

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

并发症

指标类型:

次要指标

Outcome:

complications

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

炎性因子

指标类型:

主要指标

Outcome:

inflammatory factors

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

动脉血

组织:

Sample Name:

arterial blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 40
Min age years
最大 80
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

由谢鹏程使用计算机随机数字表法

Randomization Procedure (please state who generates the random number sequence and by what method):

Xie Pengcheng uses computer random number table method

盲法:

未说明

Blinding:

Not stated

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

ResMan平台:www.medresman.org.cn.

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

ResMan platform: http://www.medresman.org.cn.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

由试验人员使用病例记录表采集数据;由数据管理员使用数据管理系统上传数据。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data will be collected by experimenters using the case record form. Data will be uploaded by the data administrator using the electronic data capture.

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above